ISTA Pharmaceuticals - PDFSEARCH.IO - Document Search Engine

ISTA Pharmaceuticals
Results: 22

#	Item
11	7 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-09-18 15:21:36 ISTA Pharmaceuticals Contact lens Alcohols Ethers Adverse effects of fluoroquinolones Azithromycin Chemistry Organic chemistry Piperazines
12	022288_Bepotastine_Clinical_PREA Add to Reading List Source URL: www.fda.gov Language: English Non-steroidal anti-inflammatory drugs Amines ISTA Pharmaceuticals Azelastine Olopatadine Norfloxacin Ketorolac Regulatory requirement Clinical trial Chemistry Organic chemistry Organochlorides
13	022288_Bepotastine_Clinpharm_PREA Add to Reading List Source URL: www.fda.gov Language: English Clinical research Design of experiments Evaluation methods Pharmacology ISTA Pharmaceuticals Allergic rhinitis Allergic conjunctivitis Clinical trial Placebo-controlled study Health Medicine Science
14	022288_Bepotastine_Statistical_PREA Add to Reading List Source URL: www.fda.gov Language: English Immunology Immune system Type 1 hypersensitivity Allergic conjunctivitis ISTA Pharmaceuticals Allergy Conjunctivitis Allergic rhinitis Allergen Medicine Health Allergology
15	NDA[removed]S-021 Page 4 Vexol® 1% (rimexolone ophthalmic suspension) DESCRIPTION VEXOL® 1% Ophthalmic Suspension is a sterile, multi-dose topical ophthalmic suspension Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-02-24 15:32:05 Blindness Uveitis Prednisolone Glaucoma Keratitis Corneal ulcer Intraocular pressure Cataract ISTA Pharmaceuticals Health Medicine Ophthalmology
16	NDA[removed]S-003 Page 3 HIGHLIGHTS OF PRESCRIBING INFORMATION Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-07-10 09:31:57 Contact lens Alcohols Ethers Piperazines Adverse effects of fluoroquinolones Betaxolol Chemistry Organic chemistry ISTA Pharmaceuticals
17	NDA[removed]S-026 Page 3 OCUFEN® (flurbiprofen sodium ophthalmic solution, USP) 0.03% Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-07-26 16:07:22 Medicine Carbachol Aspirin Ibuprofen Intraocular pressure Salicylic acid Ketorolac ISTA Pharmaceuticals Non-steroidal anti-inflammatory drugs Chemistry Organic chemistry
18	News Release Santen and Inspire Announce Approval of DIQUASTM for Dry Eye Treatment in Japan April 16, [removed]Osaka, Japan and Durham, NC --- Santen Pharmaceutical Co., Ltd. (Listed in TSE : 4536) and Inspire Pharmaceu Add to Reading List Source URL: www.santeninc.com Language: English - Date: 2013-08-06 15:12:50 Diquafosol Nucleotides Blepharitis Keratoconjunctivitis sicca Contact lens Azithromycin Ciclosporin ISTA Pharmaceuticals Health Medicine Ophthalmology
19	TECH The Eyes Have It Ophthalmic pharmaceutical Add to Reading List Source URL: www.santeninc.com Language: English - Date: 2013-08-06 15:12:51 Glaucoma Allergan Conjunctivitis Medicine Alcon Levofloxacin ISTA Pharmaceuticals Health Ophthalmology Blindness
20	Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Dermatologic and Ophthalmic Drugs Advisory Committee February 27, 2012 Topic: The committee was asked to comment on the appropr Add to Reading List Source URL: www.fda.gov Language: English ISTA Pharmaceuticals Cataract surgery Piperazines Pharmacology Non-steroidal anti-inflammatory drugs Cyclopropanes Food and Drug Administration Dermatologic and Ophthalmic Drugs Advisory Committee Medicine

UPDATE